Baird Financial Group
AIMT

Baird Financial Group’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Baird Financial Group’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-65,952
Closed -$1.1M – 1603
2020
Q2 		$1.1M Buy
65,952
+27,171
+70% +$454K ﹤0.01% 898
2020
Q1 		$559K Buy
+38,781
New +$559K ﹤0.01% 1028